NPPES file of Aug 9, 2026

Armen Isahag Yerevanian, M.D

Endocrinology, Diabetes & Metabolism Physician · Boston, MA

Armen Isahag Yerevanian, M.D is an endocrinology, diabetes & metabolism physician with a practice address in Boston, Massachusetts, and NPI 1740627231, issued on May 24, 2013. Check the license (Massachusetts 269955, as entered in NPPES) on the Massachusetts Board of Registration in Medicine; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1740627231
Name
Armen Isahag Yerevanian
Credential
M.D
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
269955 MA
Self-reported in NPPES; status is on the state search
Practice location
50 Staniford St Ste 340, Boston, MA 02114
Phone
(617) 726-8722
Enumerated
May 24, 2013
Record last updated
May 27, 2020 (not updated in 6 years: call before relying on the address or phone)
Medicare enrollment
Enrolled (PECOS I20200419000408); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 50 Staniford St Ste 340

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Rhonda Bentley-Lewis, M.D.Endocrinology, Diabetes & Metabolism Physician1508944794
  2. Sarah CohenGenetic Counselor (M.S.)1457285439
  3. Aaron Deutsch, MDEndocrinology, Diabetes & Metabolism Physician1215466586
  4. Valerie Goldman, RD LDNRegistered Dietitian1851945125
  5. Josephine Li, M.D.Endocrinology, Diabetes & Metabolism Physician1780003806
  6. Jeanna McCarthy, RDNRegistered Dietitian1437703709

Verify Armen Isahag Yerevanian in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMassachusetts Board of Registration in Medicine
    Search for license 269955
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Massachusetts license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

90% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

253 Medicare Part D claims for 59 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 75% of claims.

  1. Armen Yerevanian253
  2. Specialty average2,630

Most prescribed

  1. Ozempic39 claims
  2. Mounjaro33 claims
  3. Trulicity23 claims
  4. Genotropin14 claims
  5. Humalog Kwikpen U-10013 claims
  6. Lantus Solostar11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Bills Medicare through 2 group practices

  1. Massachusetts General Physicians Organization IncBoston, MA
  2. The General Hospital CorporationBoston, MA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Massachusetts

There are 522 endocrinology, diabetes & metabolism physician records in Massachusetts.

Other endocrinology, diabetes & metabolism physician records in Massachusetts

  1. Alice Abbott, MDLeeds, MA1922096205
  2. Adham Abdel Mottalib, MDBoston, MA1740774892
  3. Aya Abou El Nasr El Bassatne, M.D.Boston, MA1922674134
  4. Tobin Abraham, M.D.Chestnut Hill, MA1568629376
  5. Martin Abrahamson, M.D.Boston, MA1336254226
  6. Ana Paula Abreu Metzger, M.D., PHDBoston, MA1548632359
  7. Gail Adler, MD PHDBoston, MA1780675280
  8. Sara Ahmadi, M.D.Boston, MA1700082617
  9. Alexandra Albert, MD PHDWorcester, MA1164059127
  10. Erik Alexander, MDBoston, MA1285692376

Common questions

What is Armen Isahag Yerevanian, M.D's NPI number?

Armen Isahag Yerevanian, M.D's National Provider Identifier (NPI) is 1740627231, issued on May 24, 2013. An NPI identifies a provider in billing; it is not a license.

Where is Armen Isahag Yerevanian, M.D located?

The NPPES record lists a practice address at 50 Staniford St Ste 340, Boston, MA, 02114. Phone: (617) 726-8722. Providers update this record themselves, so call before visiting.

How can I verify Armen Isahag Yerevanian, M.D's license?

NPPES lists Massachusetts license number 269955, as entered by the provider. Search the Massachusetts Board of Registration in Medicine at https://findmydoctor.mass.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Armen Isahag Yerevanian, M.D prescribe under Medicare Part D?

In 2024, Armen Isahag Yerevanian, M.D had 253 Medicare Part D claims for 59 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.